DretlerSPWatsonGParrishJA, et al. Pulsed dye laser fragmentation of ureteral cal-culi: initial clinical experience. Urol J1987; 137:386–389.
2.
JohnsonDECromeensDMPriceRE. Use of the holmium: YAG laser in urology. Lasers Surg Med1992; 12(4): 353–363.
3.
JohnsonDE. Use of the holmium:YAG (Ho:YAG) laser for treatment of superficial bladder carcinoma. Lasers Surg Med1994; 14(3): 213–218.
4.
HakenbergOWComperatEMMinhasS, et al. EAU guidelines on penile cancer: 2014 update. Eur Urol2015; 67:142–150.
5.
BandieramonteGColecchiaMMarianiL, et al. Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur Urol2008; 54:875–882.
6.
BandieramonteGLeperaPMarchesiniR, et al. Laser microsurgery for superficial lesions of the penis. Urol J1987; 138:315–319.
7.
OpjordsmoenSFossåSD. Quality of life in patients treated for penile cancer. A follow-up study. Br J Urol1994; 74:652–657.
8.
ColecchiaMNicolaiNSecchiP, et al. pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy. Anal Quant Cytol Histol2009; 31:153–160.
9.
PivaLNicolaiNDi PaloA, et al. Therapeutic alternatives in the treatment of class T1N0 squamous cell carcinoma of the penis: indications and limitations. Arch Ital Urol Androl1996; 68:157.
10.
WindahlTAnderssonSO. Combined laser treatment for penile carcinoma: results after long-term followup. Urol J2003; 169:2118–2121.
11.
SchlenkerBTilkiDSeitzM, et al. Organ-preserving neodymium-yttrium-aluminium-garnet laser therapy for penile carcinoma: a long-term follow-up. BJU Int2010; 106(6): 786–790.
12.
FrimbergerDHungerhuberEZaakD, et al. Penile carcinoma. Is Nd:YAG laser therapy radical enough?Urol J2002; 168:2418.
13.
MeijerRPBoonTAvan VenrooijGE, et al. Long-term follow-up after laser therapy for penile carcinoma. Urology2007; 69:759–762.
14.
TietjenDNMalekRS. Laser therapy of squamous cell dysplasia and carcinoma of the penis. Urology1998; 52:559–565.
TangDHYanSOttenhofSR, et al. Laser ablation as monotherapy for penile squamous cell carcinoma: a multi-center cohort analysis. Urol Oncol2018; 36(4): 147–152.
17.
MusiGRussoAContiA, et al. Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life. World J Urol2018; 36:265–270.
18.
von EschenbachAC. The neodymium-yttrium aluminum garnet (Nd:YAG) laser in urology. Urol Clin North Am1986; 13:381–391.
19.
EAU. Laser of monopolar and bipolar current. EAU Guidelines. Edn. presented at the EAU Annual Congress Milan2021.
20.
SaitoS. Transurethral en bloc resection of bladder tumors. J Urol2001; 166:2148–2150.
21.
RazzaghiMRMazloomfardMMYavarM, et al. Holmium LASER in comparison with transurethral resection of the bladder tumor for non-muscle invasive bladder cancer: randomized clinical trial with 18-month follow-up. Urol J2021; 18(4): 460–465.
22.
LiCGaoLZhangJ, et al. The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Lasers Med Sci2020; 35:1025–1034.
23.
LuMLiuX. Comparison of GreenLight Laser photoselective vaporization and thulium laser enucleation for non-muscle invasive bladder cancer. Photomed Laser Surg2018; 36(7): 383–385. 9.
24.
LongGZhangYSunG, et al. Safety and efficacy of thulium laser resection of bladder tumors versus transurethral resection of bladder tumors: a systematic review and meta-analysis. Lasers Med Sci2021; 36:1807–1816.
25.
MigliariRBuffardiAGhabinH. Thulium laser endoscopic en bloc enucleation of nonmuscle-invasive bladder cancer. J Endourol2015; 29(11): 1258–1262.
26.
ZhouWWangWWuW, et al. Can a second resection be avoided after initial thulium laser endoscopic en bloc resection for non-muscle invasive bladder cancer? A retrospective single-center study of 251 patients. BMC Urol2020; 20(1): 30.
27.
KramerMWAbdelkawiIFWoltersM, et al. Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancer. Minim Invasive Ther Allied Technol2014; 23(4): 206–213.
28.
HeDFanJWuK, et al. Novel green-light KTP laser en bloc enucleation for nonmuscle-invasive bladder cancer: technique and initial clinical experience. J Endourol2014; 28(8): 975–979.
29.
TripathiMCMasoodPFSoodR, et al. A prospective study comparing side-firing KTP laser enucleation vs bipolar transurethral resection of bladder tumor for small bladder tumors in an outpatient setting. Cent Eur J Urol2021; 74:215–221.
30.
HurleRLazzeriMColomboP, et al. “En Bloc” resection of nonmuscle invasive bladder cancer: A Prospective Single-center study. Urology2016; 90:126–130.
31.
SeisenTPeyronnetBDominguez-EscrigJL, et al. Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel. Eur Urol2016; 70(6): 1052–1068.
32.
RouprêtMBabjukMCompératE, et al. European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2017 Update. Eur Urol2018; 73(1): 111–122.
33.
VergesDPLallasCDHuboskySG, et al. Endoscopic treatment of upper tract urothelial carcinoma. Curr Urol Rep2017; 18:31.
34.
HerrmannTRLiatsikosENNageleU, et al. EAU Guidelines on laser technologies. Eur Urol2012; 61(4): 783–795.
35.
VerdaasdonkRMvan SwolCFGrimbergenMC, et al. Imaging techniques for research and education of thermal and mechanical interactions of lasers with biological and model tissues. J Biomed Opt2006; 11:041110.
36.
ProiettiSRodríguez-SocarrásMEEisnerBH, et al. Thulium:YAG versus holmium:YAG laser effect on upper urinary tract soft tissue: evidence from an ex vivo experimental study. J Endourol2021; 35:544–551.
37.
DefidioLDe DominicisMDi GianfrancescoL, et al. First collaborative experience with thulium laser ablation of localized upper urinary tract urothelial tumors using retrograde intra-renal surgery. Arch Ital Urol Androl2011; 83(3): 147–153.
38.
MusiGMistrettaFAMarenghiC, et al. Thulium laser treatment of upper urinary tract carcinoma: a multi-institutional analysis of surgical and oncological outcomes. J Endourol2018; 32:257–263.
39.
BozziniGGastaldiCBesanaU, et al. Thulium-laser retrograde intra renal ablation of upper urinary tract transitional cell carcinoma: an ESUT study. Min Urol Nephrol2021; 73:114–121.
40.
SanguedolceFFontanaMTurcoM, et al. Endoscopic management of upper urinary tract urothelial carcinoma: oncologic outcomes and prognostic factors in a contemporary cohort. J Endourol2021; 35:1593–1600.
41.
DefidioLAntonucciMDe DominicisM, et al. Thulium-Holmium:YAG duo laser in conservative upper tract urothelial cancer treatment: 13 years experience from a Tertiary National Referral Center. J Endourol2019; 33(11): 902–908.
42.
BarzilayBLijovetzkyGShapiroA, et al. The clinical use of CO2 laser beam in the surgery of kidney parenchyma. Lasers Surg Med1982; 2:81–87.
43.
KyriazisIOzsoyMKallidonisP, et al. Current evidence on lasers in laparoscopy: partial nephrectomy. World J Urol2015; 33:589–594.
44.
DrerupMMagdyAHagerM, et al. Non-ischemic laparoscopic partial nephrectomy using 1318-nm diode laser for small exophytic renal tumors. BMC Urol2018; 18(1): 99.
45.
WangYShaoJLüY, et al. Thulium laser-assisted versus conventional laparoscopic partial nephrectomy for the small renal mass. Lasers Surg Med2020; 52:402–407.
46.
SartoriSMauriGTombesiP, et al. Ultrasound-guided percutaneous laser ablation is safe and effective in the treatment of small renal tumors in patients at increased bleeding risk. Int J Hyperthermia2018; 35:19–25.
47.
FerrariFMauriGNicosiaL, et al. Image-guided laser ablation in the treatment of recurrence of renal tumours: technique and preliminary results. Eur Radiol Exp2020; 4:1–5.
48.
BaierBKernAKaderaliL, et al. Retrospective survival analysis of 237 consecutive patients with multiple pulmonary metastases from advanced renal cell carcinoma exclusively resected by a 1318-nm laser. Interact Cardiovasc Throac Surg2015; 21:211–217.
49.
JandaPSrokaRMundweilB, et al. Comparison of thermal tissue effects induced by contact application of fiber guided laser systems. Lasers Surg Med2003; 33:93–101.
50.
BuiMHBredaAGuiD, et al. Less smoke and minimal tissue carbonization using a thulium laser for laparoscopic partial nephrectomy without hilar clamping in a porcine model. J Endourol2007; 21:1107–1112.
51.
van LuijtelaarAGreenwoodBMAhmedHU, et al. Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project. World J Urol2019; 37:2147–2153.
52.
LodeizenOde BruinMEggenerS, et al. Ablation energies for focal treatment of prostate cancer. World J Urol2019; 37:409–418.
53.
NatarajanSJonesTAPriesterAM, et al. Focal laser ablation of prostate cancer: feasibility of magnetic resonance imaging-ultrasound fusion for guidance. Urol J2017; 198:839–847.
54.
BrisbaneWGNatarajanSPriesterA, et al. Focal laser ablation of prostate cancer: an office procedure. J Vis Exp2021; 30:169.
55.
FelkerERRamanSSLuDSK, et al. Utility of multiparametric MRI for predicting residual clinically significant prostate cancer after focal laser ablation. AJR Am J Roentgenol2019; 213:1253–1258.
56.
PaxtonMBarbalatEPerlisN, et al. Role of multiparametric MRI in long-term surveillance following focal laser ablation of prostate cancer. Br J Radiol2022; 95:20210414.
57.
Al-HakeemYRazOGacsZ, et al. Magnetic resonance image-guided focal laser ablation in clinically localized prostate cancer: safety and efficacy. ANZ J Surg2019; 89:1610–1614.
58.
WalserENanceAYnalvezL, et al. Focal laser ablation of prostate cancer: results in 120 patients with low- to intermediate-risk disease. J Vasc Interv Radiol2019; 30:401–409.e2.
59.
RastinehadARAnastosHWajswolE, et al. Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. Proc Natl Acad Sci2019; 116:18590–18596.
60.
ChaoBLeporH. 5-year outcomes following focal laser ablation of prostate cancer. Urology2021; 155:124–129.
61.
ZhengXJinKQiuS, et al. Focal laser ablation versus radical prostatectomy for localized prostate cancer: survival outcomes from a matched cohort. Clin Genitourin Cancer2019; 17:464–469.e3.
62.
ZhouXJinKQiuS, et al. Comparative effectiveness of radiotherapy versus focal laser ablation in patients with low and intermediate risk localized prostate cancer. Sci Rep2020; 10:9112.
63.
NatarajanSRamanSPriesterAM, et al. Focal laser ablation of prostate cancer: phase I clinical trial. J Urol2016; 196:68–75.
64.
LindnerUWeersinkRAHaiderMA, et al. Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol2009; 182:1371–1377.
65.
EggenerSEYousufAWatsonS, et al. Phase II evaluation of magnetic resonance imaging guided focal laser ablation of prostate cancer. Urol J2016; 196:1670–1675.
66.
Van DerPoelHvan der BergRBriersE, et al. Focal therapy in primary localised prostate cancer: the European Association of Urology position in 2018. Eur Urol2018; 74:84–91.
67.
SandaMGCadedduJAKirkbyE, et al. Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options. Urol J2018; 199:683–690.
